TDOC Earnings Prediction
The chart below shows how TDOC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TDOC sees a +2.72% change in stock price 10 days leading up to the earnings, and a -8.08% change 10 days following the report. On the earnings day itself, the stock moves by -0.32%. This data can give you a slight idea of what to expect for the next quarter's release.
TDOC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
640.51M
-2.99%
-0.30%
Gross Margin
63.54%
10.41%
5.06%
Operating Margin
-6.30%
-28.89%
-17.75%
Net Margin
-5.20%
-39.81%
-96.01%
EPS
-0.19
-45.71%
-96.14%
No Data Available
TDOC Earnings Analysis
Teladoc Health, Inc. Corporation (TDOC.N) Earnings Conference Call
Positive
Quarterly Revenue Decline: Third quarter consolidated revenue of $641 million decreased 3% year-over-year.
Adjusted EBITDA Decline: Third quarter adjusted EBITDA was $83.3 million, down 6% year-over-year, and represented a margin of 13%.
Free Cash Flow Increase: Third quarter free cash flow was $79 million, up approximately 16% on a year-over-year basis.
Cash Reserves Status: We ended the quarter with over $1.2 billion in cash and cash equivalents on the balance sheet.
Integrated Care Revenue Increase: Integrated Care segment revenue of $384 million increased 2.5% over the prior year period, and was above the top end of our guidance range.
Negative
Quarterly Revenue Decline: Third quarter consolidated revenue of $641 million decreased 3% year-over-year.
Q3 Adjusted EBITDA Decline: Third quarter adjusted EBITDA was $83.3 million, down 6% year-over-year, and represented a margin of 13%.
Net Loss Per Share Comparison: Consolidated net loss per share in the third quarter was $0.19, compared to a net loss per share of $0.35 in the third quarter of 2023.
Net Loss Breakdown: Net loss per share in the third quarter included a amortization of acquired intangibles of $0.30 per share pre-tax, and stock-based compensation expense of $0.20 per share pre-tax.
Third Quarter Revenue Decline: Third quarter BetterHelp revenue of $257 million was down 10% versus the prior year and consistent with the baseline we had previously communicated.
TDOC FAQs
How does TDOC typically perform around its earnings report dates?
Is Teladoc Health, Inc. (TDOC) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
TDOC Earning Call Sentiment
Teladoc Health, Inc. (TDOC) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
TDOC.N
-3.76%Positive
The earnings call summary presents several challenges: declining revenue in key segments, high customer acquisition costs, and uncertainties in guidance. The Q&A reveals unclear management responses, especially regarding future investments and costs, adding to the uncertainty. Despite a strong cash position and some positive growth metrics, the withdrawal of long-term guidance and operational challenges weigh heavily. Given the company's small market cap, the stock is likely to react negatively, with a potential decline of 2% to 8% over the next two weeks.
